Clinical Trial Update: Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspepsia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting efficacy and safety of Lacidofil STRONG as an adjuvant in Helicobacter pylori treatment in non-ulcer dyspepsia, across Phase 2 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection
• Non-ulcer Dyspepsia

Drugs mentioned

• Lacidofil STRONG

Snippet

Sponsor: Lallemand Health Solutions | Conditions: Helicobacter Pylori Infection | Phase 2, Phase 3 | Status: COMPLETED